Silver Book Fact

The prevalence of age-related macular degeneration (AMD) in the 40 and older population has decreased from an estimated 9.4% from 1988 to 1994, to 6.5% for 2005 to 2008.

Klein, Ronald, Chiu-Fang Chou, Barbara E. K. Klein, Xinzhi Zhang, Stacy M. Meuer, and Jinan B. Saadine. Prevalence of Age-Related Macular Degeneration in the U.S. Population. Arch Ophthalmol. January 2011; 129(1): 75-80. http://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=3&cts=1330977849323&ved=0CDoQFjAC&url=http%3A%2F%2Farchopht.ama-assn.org%2Fcgi%2Fcontent%2Ffull%2F129%2F1%2F75&ei=NhxVT7f9N8W30AHSq6C8DQ&usg=AFQjCNGXJ3281XFLb-OelB4n3njSRegX2g

Reference

Title
Prevalence of Age-Related Macular Degeneration in the U.S. Population
Publication
Arch Ophthalmol
Publication Date
January 2011
Authors
Klein, Ronald, Chiu-Fang Chou, Barbara E. K. Klein, Xinzhi Zhang, Stacy M. Meuer, and Jinan B. Saadine.
Volume & Issue
Volume 129, Issue 1
Pages
75-80
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Screening and treatment for eye disease in all type 2 diabetes patients would result in an estimated net savings of over $472.1 million– in 1994 dollars.  
  • In general, every 10 mmHg reduction in systolic blood pressure reduces the risk of diabetes complications by 12%.  
  • Current treatments for proliferative diabetic retinopathy have reduced the rate of blindness within 5 years from 50% to less than 5%.  
  • Supplementation with lutein increases macular pigment optical density by 27%; which is correlated with benefits in visual function.  
  • High-intensity ultrasonic cyclocoagulation reduces intraocular pressure in refractory glaucoma patients.